Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28701 - 28725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	SLITRK5	26050	downregulated	Cytarabine results in decreased expression of SLITRK5 mRNA	13q31.2	A20985
Cytarabine	Approved Investigational	SLN	6588	downregulated	Cytarabine results in decreased expression of SLN mRNA	11q22.3	A21886
Cytarabine	Approved Investigational	SMAD6	4091	downregulated	Cytarabine results in decreased expression of SMAD6 mRNA	15q22.31	A21886
Cytarabine	Approved Investigational	SMOC2	64094	downregulated	Cytarabine results in decreased expression of SMOC2 mRNA	6q27	A21886
Cytarabine	Approved Investigational	SMPDL3A	10924	downregulated	Cytarabine results in decreased expression of SMPDL3A mRNA	6q22.31	A21886
Cytarabine	Approved Investigational	SNAI2	6591	downregulated	Cytarabine results in decreased expression of SNAI2 mRNA	8q11.21	A21886
Cytarabine	Approved Investigational	SNAP91	9892	upregulated	Cytarabine results in increased expression of SNAP91 mRNA	6q14.2	A21886
Cytarabine	Approved Investigational	SND1	27044	downregulated	Cytarabine results in decreased expression of SND1 mRNA	7q32.1	A21886
Cytarabine	Approved Investigational	SNF8	11267	downregulated	Cytarabine results in decreased expression of SNF8 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	SORBS2	8470	upregulated	Cytarabine results in increased expression of SORBS2 mRNA	4q35.1	A21886
Cytarabine	Approved Investigational	SOX21	11166	upregulated	Cytarabine results in increased expression of SOX21 mRNA	13q32.1	A21886
Cytarabine	Approved Investigational	SOX3	6658	upregulated	Cytarabine results in increased expression of SOX3 mRNA	Xq27.1	A21886
Cytarabine	Approved Investigational	SPAG16	79582	upregulated	Cytarabine results in increased expression of SPAG16 mRNA	2q34	A21886
Cytarabine	Approved Investigational	SPARC	6678	downregulated	Cytarabine results in decreased expression of SPARC mRNA	5q33.1	A21886
Cytarabine	Approved Investigational	SPATA7	55812	upregulated	Cytarabine results in increased expression of SPATA7 mRNA	14q31.3	A21886
Cytarabine	Approved Investigational	SPIN4	139886	downregulated	Cytarabine results in decreased expression of SPIN4 mRNA	Xq11.1	A21886
Cytarabine	Approved Investigational	SPINK1	6690	upregulated	Cytarabine results in increased expression of SPINK1 mRNA	5q32	A21886
Cytarabine	Approved Investigational	SPON1	10418	downregulated	Cytarabine results in decreased expression of SPON1 mRNA	11p15.2	A21886
Cytarabine	Approved Investigational	SPTLC3	55304	downregulated	Cytarabine results in decreased expression of SPTLC3 mRNA	20p12.1	A21886
Cytarabine	Approved Investigational	SRGAP3	9901	upregulated	Cytarabine results in increased expression of SRGAP3 mRNA	3p25.3	A21886
Cytarabine	Approved Investigational	SRGN	5552	upregulated	Cytarabine results in increased expression of SRGN mRNA	10q22.1	A20985
Cytarabine	Approved Investigational	SSUH2	51066	upregulated	Cytarabine results in increased expression of SSUH2 mRNA	3p25.3	A21886
Cytarabine	Approved Investigational	ST18	9705	upregulated	Cytarabine results in increased expression of ST18 mRNA	8q11.23	A21886
Cytarabine	Approved Investigational	ST3GAL1	6482	downregulated	Cytarabine results in decreased expression of ST3GAL1 mRNA	8q24.22	A21886
Cytarabine	Approved Investigational	ST3GAL6	10402	downregulated	Cytarabine results in decreased expression of ST3GAL6 mRNA	3q12.1	A21886

Displaying entries 28701 - 28725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability